维利西呱(Vericiguat)在国内上市了吗

Vericiguat is a new type of heart failure treatment drug. Its domestic launch, purchase channels and medical insurance coverage have attracted much attention from patients. The drug has been approved for marketing in China and has been included in the National Medical Insurance Drug List. This article will introduce in detail the domestic listing information, purchasing methods and medical insurance reimbursement status of Vericiguat.

Is Vericiguat available in China?

It has been officially approved for marketing in China, providing a new treatment option for domestic heart failure patients.

Time to market

Veliciguat was approved by the China National Medical Products Administration on May 18, 2022, with the trade name Wei Ke Tong.

Approved specifications

Veliciguat is available in three specifications in China: 2.5mg, 5mg and 10mg.

Scope of Indications

Veliciguat is approved for the treatment of adult patients with chronic heart failure with reduced ejection fraction (<45%) and stable disease after recent intravenous therapy for decompensated heart failure.

The launch of Vericiguat has filled a gap in the field of domestic heart failure treatment.

Is Vericiguat easy to buy?

Vericiguat needs to be purchased through formal medical channels, and it is relatively convenient to obtain.

Purchase in hospital

Patients can go to the cardiovascular department of the hospital or a large general hospital, and then buy Veliciguat with a prescription in the hospital pharmacy, especially in medical institutions with heart failure departments.

Purchasing in pharmacies

Some large chain pharmacies can provide Vericiguat. A valid prescription issued by a doctor is required. Purchases from designated pharmacies under medical insurance can be reimbursed.

Purchasing Precautions

Check the drug approval number and manufacturer to avoid buying counterfeit drugs, which must be stored below 30°C.

With medical insurance coverage, the accessibility of Vericiguat is gradually increasing.

Is Vericiguat included in the national medical insurance?

Vericiguat has been included in the national medical insurance drug catalog, which greatly reduces the financial burden on patients.

Time for inclusion in medical insurance

Veliciguat will be included in the national medical insurance drug catalog in 2023.

Reimbursement ratio

The specific reimbursement ratio varies by region, usually between 50% and 70%. The local reimbursement ratio shall prevail.

Medical insurance coverage has significantly improved the accessibility of vericiguat, allowing more patients to obtain this innovative treatment.